Charles Schwab Investment Management Inc Syros Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.69 - $1.21 $87,621 - $153,655
-126,988 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$1.02 - $3.8 $16,060 - $59,834
-15,746 Reduced 11.03%
126,988 $152,000
Q4 2021

Feb 11, 2022
SELL
$3.26 - $4.66 $182 - $260
-56 Reduced 0.04%
142,734 $466,000
Q3 2021

Nov 16, 2021
SELL
$4.08 - $5.66 $1.02 Million - $1.41 Million
-249,008 Reduced 63.56%
142,790 $639,000
Q2 2021

Aug 16, 2021
BUY
$5.01 - $7.48 $143,441 - $214,159
28,631 Added 7.88%
391,798 $2.14 Million
Q1 2021

May 17, 2021
BUY
$7.19 - $14.95 $864,388 - $1.8 Million
120,221 Added 49.48%
363,167 $2.72 Million
Q4 2020

Feb 16, 2021
SELL
$6.66 - $14.66 $1,118 - $2,462
-168 Reduced 0.07%
242,946 $2.64 Million
Q3 2020

Nov 13, 2020
SELL
$8.69 - $14.47 $67,564 - $112,504
-7,775 Reduced 3.1%
243,114 $2.15 Million
Q2 2020

Aug 14, 2020
BUY
$5.21 - $11.03 $238,216 - $504,324
45,723 Added 22.29%
250,889 $2.68 Million
Q1 2020

May 15, 2020
SELL
$4.46 - $9.2 $820 - $1,692
-184 Reduced 0.09%
205,166 $1.22 Million
Q4 2019

Feb 07, 2020
BUY
$4.52 - $10.1 $28,277 - $63,185
6,256 Added 3.14%
205,350 $1.42 Million
Q3 2019

Nov 08, 2019
SELL
$7.14 - $11.65 $34,800 - $56,782
-4,874 Reduced 2.39%
199,094 $2.07 Million
Q2 2019

Aug 09, 2019
BUY
$5.5 - $9.75 $500,945 - $888,039
91,081 Added 80.68%
203,968 $1.89 Million
Q1 2019

May 14, 2019
SELL
$5.51 - $9.59 $77,900 - $135,583
-14,138 Reduced 11.13%
112,887 $1.03 Million
Q4 2018

Feb 14, 2019
SELL
$5.55 - $11.34 $11,277 - $23,042
-2,032 Reduced 1.57%
127,025 $708,000
Q3 2018

Nov 13, 2018
BUY
$9.74 - $12.92 $165,229 - $219,174
16,964 Added 15.13%
129,057 $1.54 Million
Q2 2018

Aug 08, 2018
BUY
$10.16 - $13.65 $359,186 - $482,568
35,353 Added 46.07%
112,093 $1.15 Million
Q1 2018

May 07, 2018
BUY
$9.47 - $12.98 $315,493 - $432,428
33,315 Added 76.72%
76,740 $997,000
Q4 2017

Jan 17, 2018
BUY
$8.45 - $17.48 $14,500 - $29,995
1,716 Added 4.11%
43,425 $423,000
Q3 2017

Nov 13, 2017
BUY
$13.52 - $23.75 $563,905 - $990,588
41,709
41,709 $614,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $5.67M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email